GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes

J Mol Biol. 2000 Dec 15;304(5):995-1005. doi: 10.1006/jmbi.2000.4260.

Abstract

The antibiotic GE2270A prevents stable complex formation between elongation factor Tu (EF-Tu) and aminoacyl-tRNA (aatRNA). In Escherichia coli we characterized two mutant EF-Tu species with either G257S or G275A that lead to high GE2270A resistance in poly(Phe) synthesis, which at least partially explains the high resistance of EF-Tu1 from GE2270A producer Planobispora rosea to its own antibiotic. Both E. coli mutants were unexpectedly found to bind GE2270A nearly as well as wild-type (wt) EF-Tu in their GTP-bound conformations. Both G257S and G275A are in or near the binding site for the 3' end of aatRNA. The G257S mutation causes a 2.5-fold increase in affinity for aatRNA, whereas G275A causes a 40-fold decrease. In the presence of GE2270A, wt EF-Tu shows a drop in aatRNA affinity of at least four orders of magnitude. EF-Tu[G275S] and EF-Tu[G275A] curtail this drop to about two or one order, respectively. It thus appears that the resistance mutations do not prevent GE2270A from binding to EF-Tu.GTP and that the mutant EF-Tus may accommodate GE2270A and aatRNA simultaneously. Interestingly, in their GDP-bound conformations the mutant EF-Tus have much less affinity for GE2270A than wt EF-Tu. The latter is explained by a recent crystal structure of the EF-Tu.GDP.GE2270A complex, which predicts direct steric problems between GE2270A and the mutated G257S or G275A. These mutations may cause a dislocation of GE2270A in complex with GTP-bound EF-Tu, which then no longer prevents aatRNA binding as in the wt situation. Altogether, the data lead to the following novel resistance scenario. Upon arrival of the mutant EF-Tu.GTP.GE2270.aatRNA complex at the ribosomal A-site, the GTPase centre is triggered. The affinities of aatRNA and GE2270A for the GDP-bound EF-Tu are negligible; the former stays at the A-site for subsequent interaction with the peptidyltransferase centre and the latter two dissociate from the ribosome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actinomycetales / chemistry
  • Adenine / metabolism
  • Amino Acid Substitution / genetics
  • Aminoglycosides*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Microbial
  • Escherichia coli* / chemistry
  • Escherichia coli* / drug effects
  • Escherichia coli* / genetics
  • Guanosine Diphosphate / metabolism
  • Guanosine Triphosphate / metabolism*
  • Models, Molecular
  • Mutation / genetics*
  • Peptide Elongation Factor Tu / chemistry
  • Peptide Elongation Factor Tu / genetics*
  • Peptide Elongation Factor Tu / metabolism*
  • Peptides / metabolism
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / pharmacology*
  • Poly U / genetics
  • Poly U / metabolism
  • Protein Binding / drug effects
  • Protein Biosynthesis / drug effects
  • Protein Conformation
  • RNA, Bacterial / genetics
  • RNA, Bacterial / metabolism
  • RNA, Transfer, Amino Acyl / genetics
  • RNA, Transfer, Amino Acyl / metabolism*
  • Thermodynamics
  • Thermus / chemistry
  • Thiazoles / chemistry
  • Thiazoles / metabolism*
  • Thiazoles / pharmacology

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Peptides
  • Peptides, Cyclic
  • RNA, Bacterial
  • RNA, Transfer, Amino Acyl
  • Thiazoles
  • pulvomycin
  • Guanosine Diphosphate
  • Poly U
  • polyphenylalanine
  • Guanosine Triphosphate
  • Peptide Elongation Factor Tu
  • Adenine
  • GE 2270 A